	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	-	47.77	63.47	53.36	147.95	155.60	58.43	36.81	43.72	17.84	48.76	175.68	8.47	27.20	89.71	118.14
Cost of Operating Revenue	0.18	5.54	15.21	53.82	94.75	100.93	19.29	3.17	13.83	2.99	14.38	32.42	3.82	5.18	32.52	43.84
Gross Profit	-0.18	42.23	48.26	-0.46	53.20	54.67	39.15	33.64	29.89	14.85	34.38	143.26	4.65	22.03	57.19	74.29
Gross Margin	-	88.4	76.0	-0.9	36.0	35.1	67.0	91.4	68.4	83.2	70.5	81.5	54.9	81.0	63.8	62.9
Total Operating Expenses	4.25	12.94	31.22	65.17	113.81	112.10	68.59	82.71	66.90	33.35	42.33	47.39	22.18	36.80	76.20	109.09
Operating Profit	-4.25	34.83	32.25	-11.81	34.14	43.50	-10.15	-45.89	-23.18	-15.51	6.43	128.28	-13.71	-9.60	13.51	9.05
Operating Margin	-	72.9	50.8	-22.1	23.1	28.0	-17.4	-124.7	-53.0	-86.9	13.2	73.0	-161.8	-35.3	15.1	7.7
Financing Income/(Expense) - Net	2.96	11.65	-20.48	-21.82	-51.18	-47.17	-50.85	-59.20	-69.12	-61.31	-68.15	-10.09	-5.53	-3.95	-22.02	-35.37
Profit before Taxes	0.73	44.78	8.22	-30.66	4.55	-1.58	-60.49	-116.29	-90.65	-80.62	-95.22	262.56	61.58	-8.85	-7.39	5.11
Income Taxes	0.14	9.11	5.41	2.63	4.22	-9.80	1.58	0.03	2.70	-	0.00	24.79	-4.96	-0.29	1.50	2.82
Profit after Tax	0.59	35.69	2.81	-25.41	4.87	13.88	-62.06	-116.32	-93.35	-80.62	-95.23	143.77	66.43	-6.73	-6.80	5.00
PAT Margin	-	74.7	4.4	-47.6	3.3	8.9	-106.2	-316.0	-213.5	-451.9	-195.3	81.8	784.0	-24.8	-7.6	4.2
EPS - Basic - ex Extraordinary Items	0.02	1.46	0.12	-1.04	0.20	0.57	-2.53	-4.77	-3.83	-3.30	-3.90	5.87	2.64	-0.26	-0.26	0.19
EPS - Diluted - ex Extraordinary Items	0.02	1.46	0.12	-1.04	0.20	0.57	-2.53	-4.77	-3.83	-3.30	-3.90	5.87	2.64	-0.26	-0.26	0.19
EBIT	-4.25	34.83	32.25	-11.81	34.14	43.50	-10.15	-45.89	-23.18	-15.51	6.43	128.28	-13.71	-9.60	13.51	9.05
EBITDA	11.07	50.16	47.64	3.97	35.30	44.61	-9.07	-44.19	-20.72	-13.55	7.30	129.40	-11.81	-7.55	27.18	27.84
EBITDA Margin	-	105.0	75.1	7.4	23.9	28.7	-15.5	-120.0	-47.4	-75.9	15.0	73.7	-139.4	-27.8	30.3	23.6

Balance Sheet

Abridged

Understanding Balance Sheet

Evervie Health Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	R 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	R 2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	3	19	23	299	611	556	517	460	416	404	364	316	63	57	146
Long-Term Investments	166	167	148	48	61	54	46	34	30	18	15	10	3	2	21
Property Plant & Equipment - Net	325	310	3	2	7	13	13	12	14	5	4	4	7	7	100
Total Non-Current Assets	777	777	755	203	209	220	212	209	195	162	141	23	316	317	637
Total Assets	779	796	778	501	821	776	728	669	611	566	505	339	379	375	783
Total Current Liabilities	76	129	102	76	293	248	254	292	386	465	549	95	67	43	136
Long Term Debt	162	142	165	134	169	185	204	241	183	144	127	69	3	2	162
Total Non-Current Liabilities	285	228	248	217	251	244	252	287	229	186	136	135	83	112	250
Total Liabilities	361	357	350	293	545	492	506	579	615	650	685	231	150	155	386
Total Shareholders' Equity	417	438	427	215	235	249	212	130	68	11	-46	148	230	222	218
Minority Interest	1	1	1	-7	41	36	10	-39	-72	-96	-134	-40	0	-2	179
Total Equity	418	439	428	208	276	284	222	91	-4	-84	-180	108	230	220	397
Total Liabilities & Equity	779	796	778	501	821	776	728	669	611	566	505	339	379	375	783

Cash Flow

Abridged

Understanding Cash Flow Statement

Evervie Health Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	-3.27	50.68	15.84	-25.04	36.24	15.66	-47.29	-14.26	13.95	16.00	25.05	261.71	-12.12	-22.90	13.05
Working Capital - Increase/(Decrease)	-3.02	-48.70	-43.94	81.09	-27.15	50.87	-2.12	-12.95	-5.39	-8.85	-38.15	65.19	11.83	42.80	-40.21
Net CF from Operating Activities	-6.29	1.98	-28.09	56.05	9.09	66.53	-49.41	-27.21	8.57	7.15	-13.10	326.91	-0.29	19.91	-27.15
Capital Expenditures - Net	1.05	-20.61	1.64	0.18	0.32	1.43	1.55	0.73	-0.08	-0.02	-	-	-	-	28.17
Net CF from Investing Activities	-0.68	19.45	5.05	-35.27	3.63	-7.00	-1.65	9.23	0.08	6.87	-7.86	-123.58	6.27	1.30	-155.48
Stock - Issuance/(Retirement) - Net	-	-	-	0.04	-	-	-	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-10.41	-20.88	23.02	-21.88	-12.47	-54.82	46.47	18.48	-10.11	-10.44	17.36	-115.64	-7.40	-21.35	195.91
Net Cash Flow from Financing Activities	-10.41	-20.88	23.02	-21.84	-12.47	-54.82	46.47	18.48	-10.11	-10.44	17.36	-201.97	-7.40	-21.35	195.91
Free Cash Flow to Equity	-17.76	1.72	-6.71	33.99	-3.70	10.28	-4.49	-9.46	-1.47	-3.26	4.26	211.27	-7.69	-1.44	140.59
Free Operating CF net dividend	-7.35	1.61	-29.73	55.87	8.77	64.99	-51.21	-27.98	8.45	7.13	-13.10	326.91	-0.29	19.91	-55.32
Free Operating CF	-7.35	1.61	-29.73	55.87	8.77	64.99	-51.21	-27.98	8.45	7.13	-13.10	326.91	-0.29	19.91	-55.32

Business Segment Analysis

FY End:

Mar 26

Evervie Health Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales

Health Care Services (63.3%)₹ 56.79 CrReal Estate (36.7%)₹ 32.92 Cr

Assets

Real Estate (68.6%)₹ 537.40 CrHealth Care Services (31.4%)₹ 245.58 Cr

Regional Segment Analysis

FY End:

Mar 26

Evervie Health Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (100.0%)₹ 89.71 Cr

Historical Segment Analysis

Track how Evervie Health Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2010 Mar 31	2011 Mar 31	2012 Mar 31
	2010 Mar 31	2011 Mar 31	2012 Mar 31
Media & Entertainment	0	-	-
Others	0	0	0
Power and Energy	0	-	-
Property Related Services	3	3	1

Frequently Asked Questions

What is the revenue of Evervie Health Ltd.?

The latest trailing twelve month revenue of Evervie Health Ltd. is ₹ 118.14 Cr, reflecting a 1-year growth of 181.99% and a 3-year CAGR of 94.20%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Evervie Health Ltd.?

The latest trailing twelve month net profit (PAT) of Evervie Health Ltd. is ₹ 3.98 Cr, with a 3-year earnings CAGR of -26.88%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Evervie Health Ltd.?

The trailing twelve month EBITDA of Evervie Health Ltd. is approximately ₹ 7.86 Cr (based on an operating margin of 6.65%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Evervie Health Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Evervie Health Ltd. is 0.19. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Evervie Health Ltd.?

The debt-to-equity ratio of Evervie Health Ltd. stands at 1.18. The interest coverage ratio is 0.26x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Evervie Health Ltd.?

The estimated book value per share of Evervie Health Ltd. is 8.38 (derived from a P/B ratio of 5.85 and market price of ₹ 49.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Evervie Health Ltd.?

The trailing twelve month operating cash flow of Evervie Health Ltd. is ₹ -27.89 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Evervie Health Ltd. report consolidated or standalone financials?

Evervie Health Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.